Clicky

Recordati Industria Chim(RCDTF) News

Date Title
Oct 4 Sanofi Sells Global Rights To Rare Autoimmune Drug Enjaymo For $825M Upfront To Italian Firm Recordati
Oct 4 Sanofi’s rare disease drug finds yet another home
Oct 4 Recordati to acquire worldwide rights to Sanofi’s antibody Enjaymo
Oct 4 RECORDATI ANNOUNCES AGREEMENT TO ACQUIRE THE GLOBAL RIGHTS TO ENJAYMO®, STRENGTHENING ITS RARE DISEASES FRANCHISE
Jun 18 KKR, TPG Express Interest in Italian Drugmaker Recordati